MiR-690 Treatment Causes Decreased Fibrosis and Steatosis and Restores Specific Kupffer Cell Functions in NASH

MiR-690 directly inhibited fibrogenesis in hepatic stellate cells, inflammation in recruited hepatic macrophages, and de novo lipogenesis in hepatocytes.